Genopathy
Gene-Disorder Association · Article
Gene
SLC6A3
Solute Carrier Family 6 Member 3
Disorder
Movement Disease
First reported 2002
Supporting publications 1
Key publication · gene–disorder The feasibility of statistical parametric mapping for the analysis of positron emission tomography studies using 11C-2-beta-carbomethoxy-3-beta-(4-fluorophenyl)-tropane in patients with movement disorders.Nuclear medicine communications · 2002
Key publication · disorder [The late result of surgery of extrapyramidal movement disorders and paraplegias].Deutsche Zeitschrift fur Nervenheilkunde · 1952
Manually curated
Association Review

In brief

The association between SLC6A3 (Solute Carrier Family 6 Member 3) and Movement Disease is reported, with clinical genetic testing available.

Sources 1
Clinical variants 0
Symptoms 28
Compounds 0
Trials 0
Publications 1
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
SLC6A3

The gene

2 source summaries

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Movement Disease

The disorder

6 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Literature

Reading

1 publication

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access
06
Provenance

References & sources

5 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access